TRβ agonist 1 

TRβ agonist 1 is a selective and mutation-sensitive thyroid hormone receptor β (TRβ) agonist, with an EC₅₀ value of 21 nM. TRβ agonist 1 can be used for researching dyslipidemia, nonalcoholic steatohepatitis (NASH), and resistance to thyroid hormone (RTH)^[1].

EC₅₀: 21.0 nM [TRβ (WT)], 1344.0 nM [TRβ (H435R)]^[1]

TRβ agonist 1 (compound 16g) (1, 3, 10 μM; 24 hours) reduces lipid accumulation and cholesterol levels by triglyceride (TG) and total cholesterol (TC) analyses in HepG2 cells and primary mouse hepatocytes; also reduces the total lipid accumulation at 10 μM^[1].
TRβ agonist 1 (10 μM; 24 hours) induces a significant enhancement of the p-AMPK/AMPK ratio, the p-ACC/ACC ratio, and CPT1 levels^[1].
TRβ agonist 1 (0.01, 0.1, 1 and 10 μM; 24 hours) does not display significant cellular toxicity on multiple cell lines (HepG2, 22Rv1, A549, MCF7, MDA-MB-231, HFL-1, and BxPC-3) at concentrations up to 10 μM^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

548.52

C₂₉H₂₅FN₂O₈

2770681-85-9

O=C(C1=C(C2=CC=C(C=C2C(OC)=N1)OC3=C(C=C(C=C3C)C(C4=CC(OC)=CC(F)=C4)=O)C)O)NCC(O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Li Q, et al. Discovery of a Highly Selective and H435R-Sensitive Thyroid Hormone Receptor β Agonist. J Med Chem. 2022;65(10):7193-7211.  [Content Brief]